Epigral Limited (NSE:EPIGRAL)

Market Cap	76.58B
Revenue (ttm)	25.50B
Net Income (ttm)	3.58B
Shares Out	43.14M
EPS (ttm)	84.68
PE Ratio	20.96
Forward PE	18.34
Dividend	7.00 (0.39%)
Ex-Dividend Date	Jun 20, 2025

Volume	19,481
Average Volume	38,268
Open	1,797.10
Previous Close	1,784.00
Day's Range	1,764.90 - 1,797.10
52-Week Range	1,110.05 - 2,406.75
Beta	-0.14
RSI	43.13
Earnings Date	Jul 25, 2025

About Epigral

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda, chlorine, hydrogen, and caustic potash products. It also engages in the trading of agrochemical products. It serves various sectors, including CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and dete...

• Industry: Chemicals
• Sector: Materials
• Founded: 2007
• Employees: 997
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: EPIGRAL

Financial Performance

In 2024, Epigral's revenue was 25.50 billion, an increase of 32.19% compared to the previous year's 19.29 billion. Earnings were 3.58 billion, an increase of 82.62%.